-
- Posts: 656
- Joined: Tue Jul 05, 2005 7:45 am
In one of our API's, there is a small impurity peak present at about 0.05-0.07%. The daily dose of the drug is high (>2g /day)
The LC methods for the API and the finished product are very different, and we have never seen this impurity in the finished product.
Question 1: if we can assure that we cannot detect the impurity in the product, do we still need to identify and qualify the impurity?
I have tried to identify the impurity via LC-MS, and I have got the exact mass, and MS/MS fragmentation of the impurity. This is however not enough for identification, and I guess the next step would be NMR analysis. The problem is that the impurity, after fraction collection, degrades totally within 30 minutes. It seems to be protected in the sample solution, where it doesn't decrease (or increase) over time. I would need many fraction collections to get enough material for an NMR analysis (acc. to the external NMR lab)
Question 2: Any ideas of how to proceed?
Thanks!

